Expert Ratings for Gilead Sciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock, with an average 12-month price target of $91.29. The average price target has increased by 5.9% over the past month.
June 23, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gilead Sciences (NASDAQ:GILD) has an average 12-month price target of $91.29 according to 7 analysts, with a 5.9% increase over the past month.
The average 12-month price target for Gilead Sciences has increased by 5.9% over the past month, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors may see this as a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100